TPG Inc. (TPG): Price and Financial Metrics
GET POWR RATINGS... FREE!
TPG Stock Price Chart Interactive Chart >
TPG Price/Volume Stats
| Current price | $28.57 | 52-week high | $35.40 |
| Prev. close | $27.69 | 52-week low | $23.09 |
| Day low | $27.76 | Volume | 535,300 |
| Day high | $28.79 | Avg. volume | 622,914 |
| 50-day MA | $29.94 | Dividend yield | 5.46% |
| 200-day MA | $0.00 | Market Cap | 8.82B |
TPG Inc. (TPG) Company Bio
TPG Inc. operates as an alternative asset manager worldwide. It offers investment management services to unconsolidated funds, collateralized loan obligations, and other vehicles; monitoring services to portfolio companies; advisory services, debt and equity arrangements, and underwriting and placement services; and capital structuring and other advisory services to portfolio companies. The company invests in private equity funds, real estate funds, fund of hedge funds, and credit funds. TPG Inc. was founded in 1992 and is based in Fort Worth, Texas.
Latest TPG News From Around the Web
Below are the latest news stories about TPG INC that investors may wish to consider to help them evaluate TPG as an investment opportunity.
Peter Munzig joins TPG as PartnerSAN FRANCISCO & FORT WORTH, Texas, August 22, 2022--TPG, a global alternative asset management firm, announced today the appointment of Peter Munzig as a Partner and Head of Business Services for TPG Capital, the firm’s private equity platform. In his role, Munzig will lead TPG Capital’s investment activity and portfolio management in the business services sector. |
Private-Equity Firms Look to Foreign Cash as U.S. Pension Funds StruggleSovereign-wealth funds benefiting from the high price of oil have become a greater share of private-equity fundraising this year, say buyout firms |
TPG weighing roughly $2 bln sale of diagnostics company Immucor: ReportTPG Inc. is considering the sale of portfolio company Immucor Inc., a Norcross, Ga.-based specialist in blood transfusion and transplantation diagnostics, according to a report Thursday by Bloomberg. The business is expected to draw a price of about $2 billion, with interest from other private equity firms as well as companies in related businesses, the report said. TPG took Immucor private in 2011 for $27 per share in cash or about $1.94 billion. Shares of TPG closed at $32.39 on Wednesday, up |
Earnings Season Shows Private-Equity Firms Bracing for Slower FundraisingPublicly traded private-equity firms predict longer fundraising periods as they navigate tougher market conditions. |
BMO Capital Sticks to Its Hold Rating for TPG (TPG)BMO Capital analyst Rufus Hone maintained a Hold rating on TPG (TPG - Research Report) today and set a price target of $37.00. The company's shares opened today at $32.29.According to TipRanks, Hone is an analyst with an average return of -6.7% and a 34.48% success rate. Hone covers the Financial sector, focusing on stocks such as Apollo Global Management, TPG, and Blackstone Group.TPG has an analyst consensus of Moderate Buy, with a price target consensus of $33.25, implying a 2.97% upside from current levels. In a report released today, Goldman Sachs also maintained a Hold rating on the stock with a $31.00 price target. |
TPG Price Returns
| 1-mo | -3.84% |
| 3-mo | 18.86% |
| 6-mo | -4.72% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
TPG Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...